INTERNATIONAL PATENT: ADALVO LIMITED, WIN MEDICA S.A. FILES APPLICATION FOR "A FIXED-DOSE PHARMACEUTICAL COMPOSITION COMPRISING (2S)-2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)OXY]-3-METHOXY-3,3-DIPHENYLPROPANOIC ACID AND (6R,12AR)-6-(1,3-BENZODIOXOL-5-YL)-2-METHYL-2,3,6,7,12,12A-HEXAHYDROPYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE"

GENEVA, Feb. 2 -- ADALVO LIMITED (Malta Life Science Park Building 1Level 4 / Sir Temi Zammit BuildingsSan Gwann Industrial EstateSan Gwann, SGN 3000), WIN MEDICA S.A. (6-8 Agisilaou Str.15123 Marousi, Attica) filed a patent application (PCT/EP2025/071204) for "A FIXED-DOSE PHARMACEUTICAL COMPOSITION COMPRISING (2S)-2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)OXY]-3-METHOXY-3,3-DIPHENYLPROPANOIC ACID AND (6R,12AR)-6-(1,3-BENZODIOXOL-5-YL)-2-METHYL-2,3,6,7,12,12A-HEXAHYDROPYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE" on Jul 23, 2025. With publication no. WO/2026/022235, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system,...